Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
5 Relatively Safe And Cheap Dividend Stocks To Invest In - February 2023
09:00am, Saturday, 04'th Feb 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. It's alwa
AbbVie Q4 Preview: What's in Store?
10:31pm, Friday, 03'rd Feb 2023 Zacks Investment Research
AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.
AbbVie Q4 Preview: What's in Store?
06:49pm, Friday, 03'rd Feb 2023
AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.
Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits
02:19pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals court dismisses J&J's (JNJ) bankruptcy filing related to its talc lawsuits.
Top Fund Manager Found A Way To Make Money While Others Lose
07:00am, Friday, 03'rd Feb 2023
Making money in an up market is easy. But showering investors with gains when stocks fall is far more challenging for the best mutual funds.
S&P 500 surges to end at over five-month high, Nasdaq closes up 3.3% as Meta leads rally in tech sector stocks
09:29pm, Thursday, 02'nd Feb 2023 MarketWatch
U.S. stocks ended mostly higher on Thursday after the Nasdaq Composite and the S&P 500 index surged to their highest levels in about five months, buoyed by upbeat results from Facebook parent Meta Pla
Merck (MRK) Q4 2022 Earnings Call Transcript
07:30pm, Thursday, 02'nd Feb 2023 The Motley Fool
MRK earnings call for the period ending December 31, 2022.
Why These 2 Stocks Made the Dow Miss the Market Rally
04:11pm, Thursday, 02'nd Feb 2023 The Motley Fool
Even as the S&P 500 climbed, weaker performance from Dow components held the average back.
Economic Data Deluge
04:04pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Economic Data Deluge.
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
03:53pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Merck (MRK) beats Q4 estimates for earnings and sales. Its 2023 profit guidance disappoints. Stock declines in pre-market.
Goldilocks Econ Data Presides Over Pre-Market
03:39pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
We haven't thrown around the term "Goldilocks" too much lately, but this morning, the shoe fits.
Merck, Eli Lilly stocks fall over earnings, outlook concerns
03:30pm, Thursday, 02'nd Feb 2023
Senior reporter Anjalee Khemlani joins Yahoo Finance Live to discuss how pharma stocks are faring after reporting earnings.
Pharma earnings: COVID ‘is highly uncertain for this year,' analyst says
02:36pm, Thursday, 02'nd Feb 2023
Pharma Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live anchors Rachelle Akuffo and Anjalee Khemlani to discuss pharmaceutical earnings amid COVID uncertainty, the impact of diabeti
The 7 Most Undervalued Dow Stocks to Buy in February 2023
02:35pm, Thursday, 02'nd Feb 2023
While investing in the new normal seemingly focused on meme trades and other high-risk ventures, targeting the companies of the Dow Jones is always relevant, particularly if they're among the most und
Merck (MRK) Beats Q4 Earnings and Revenue Estimates
12:55pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Merck (MRK) delivered earnings and revenue surprises of 3.85% and 0.65%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
